Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 3/20 | 0.38 |
| ▸ | MAOB | P27338 | 3/20 | 0.38 |
| ▸ | CES2 | O00748 | 2/20 | 0.36 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9331119 | 0.93 | MAPT (0.52) | CA1CA2CA9CYP2A6MAPT | |
| SCHEMBL3363886 | 0.80 | LDHA (0.42) | CA1CA2CA9CYP2A6MAPT | |
| SCHEMBL8476586 | 0.80 | MAPT (0.41) | CA1CA2CA9CYP2A6MAPT | |
| SCHEMBL13805761 | 0.76 | LTA4H (0.43) | CA1CA2CA9MAOAMAOB | |
| SCHEMBL14147885 | 0.75 | MAPT (0.37) | CA1CA2CA9CYP2A6MAPT | |
| SCHEMBL233807 | 0.74 | CA1 (0.58) | CA1CA2CA9CYP2A6MAPT | |
| SCHEMBL4074415 | 0.74 | ALDH1A1 (0.50) | MAPTMAPK1MEN1RAB9AKMT2A | |
| SCHEMBL4408434 | 0.74 | MEN1 (0.43) | CA1CA2CA9CYP2A6MAPT | |
| SCHEMBL2439922 | 0.74 | MEN1 (0.50) | CA1CA2CA9MAPTMEN1 | |
| SCHEMBL1416559 | 0.74 | ACHE (0.48) | CA1CA2CA9MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120195931-A | Colored resin composition, color filter and display device | 住友化学株式会社 | 2025-06-24 | — | — | CN | disclosed |
| US-20250145760-A1 | EPOXY RESIN COMPOSITIONS COMPRISING DICYANDIAMID CURING AGENT | 3M INNOVATIVE PROPERTIES COMPANY | 2025-05-08 | — | — | US | disclosed |
| CN-113677687-B | Light absorbing composition and optical filter | 日本板硝子株式会社 | 2025-04-25 | — | — | CN | disclosed |
| CN-119790328-A | Light-absorbing composition, light absorber, optical filter, ambient light sensor, imaging device, method for producing light-absorbing composition, and method for producing light absorber | 日本板硝子株式会社 | 2025-04-08 | — | — | CN | disclosed |
| CN-119404118-A | Light absorber, light-absorbing compound, dispersion of light-absorbing compound, light-absorbing composition, optical filter, photoelectric conversion element, ambient light sensor, and imaging device | 日本板硝子株式会社 | 2025-02-07 | — | — | CN | disclosed |
| EP-4442746-A1 | EPOXY RESIN COMPOSITIONS SUITABLE FOR BONDING TO OILY SURFACE | 3M Innovative Properties Company (US) | 2024-10-09 | — | — | EP | disclosed |
| CN-118679172-A | Process for producing phenylphosphonate and phenylphosphonate compound | 日产化学株式会社 | 2024-09-20 | — | — | CN | disclosed |
| CN-118647907-A | Optical filter, light absorbing composition, method of manufacturing optical filter, sensing device, and sensing method | 日本板硝子株式会社 | 2024-09-13 | — | — | CN | disclosed |
| CN-114031639-B | Preparation method of biphospide with P-O-C-P structure | 烟台大学 | 2024-07-12 | — | — | CN | disclosed |
| WO-2024083210-A1 | COMPOUNDS, COMPOSITIONS AND METHODS THEREOF | HEPAITECH (BEIJING) BIOPHARMA TECHNOLOGY CO., LTD. (CN) | 2024-04-25 | — | — | WO | disclosed |
| EP-1640405-A1 | RESIN AND ARTICLE MOLDED THEREFROM | TORAY INDUSTRIES, INC. (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20050239054-A1 | Method and compositions for identifying anti-HIV therapeutic compounds | GILEAD SCIENCES. INC. | 2005-10-27 | — | — | US | disclosed |
| US-20050209197-A1 | Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds | GILEAD SCIENCES, INC. | 2005-09-22 | — | — | US | disclosed |
| WO-2005064008-A1 | METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| EP-1509537-A2 | CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH | GILEAD SCIENCES, INC. (US) | 2005-03-02 | — | — | EP | disclosed |
| WO-2004100960-A2 | ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2004-11-25 | — | — | WO | disclosed |
| US-6750313-B2 | HIGH REFRACTIVE INDEX AND LOW DISPERSION CHARACTERISTICS; OPTICAL LENSES, FILMS, DISCS; POLYCARBONATE RESIN CONTAINING A PHOSPHONIC ACID GROUP | TORAY INDUSTRIES, INC. (JP) | 2004-06-15 | — | — | US | disclosed |
| WO-2003090690-A2 | CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH | GILEAD SCIENCES, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| US-20030013836-A1 | Resin composition and articles molded therefrom | TORAY INDUSTRIES, INC., A CORPORATION OF JAPAN (JP) | 2003-01-16 | — | — | US | disclosed |
| EP-1270646-A1 | RESIN COMPOSITION AND ARTICLES MOLDED THEREFROM | TORAY INDUSTRIES, INC. (JP) | 2003-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250145760-A1 | EPOXY RESIN COMPOSITIONS COMPRISING DICYANDIAMID CURING AGENT | DDAH1, PHOSPHO1, QDPR | CA1 496/4885CA2 562/4885CA9 1398/4885 |
| US-20050209197-A1 | Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds | PPA1, PPME1, PNP | CA1 3711/4885CA2 3935/4885CA9 3725/4885 |
| US-20050239054-A1 | Method and compositions for identifying anti-HIV therapeutic compounds | CES1, PNP, PGLS | CA1 3093/4885CA2 3487/4885CA9 1893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.